Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s40425-019-0804-9.

Title:
Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity | Journal for ImmunoTherapy of Cancer
Description:
Background Pre-clinical and clinical studies have shown that the infusion of CAR T cells with a naive-like (TN) and central memory (TCM) phenotype is associated with prolonged in vivo T cell persistence and superior anti-tumor effects. To optimize the maintenance of such populations during the in vitro preparation process, we explored the impact of T cell exposure to both traditional [fetal bovine serum (FBS), human AB serum (ABS)] and non-traditional [human platelet lysate (HPL) - a xeno-free protein supplement primarily used for the production of clinical grade mesenchymal stromal / stem cells (MSCs)] serum supplements. Methods Second generation chimeric antigen receptor with CD28 and CD3ζ endodomain targeting prostate stem cell antigen (PSCA) (P28z) or CD19 (1928z) were constructed and used for this study. After retroviral transduction, CAR T cells were divided into 3 conditions containing either FBS, ABS or HPL and expanded for 7 days. To evaluate the effect of different sera on CAR T cell function, we performed a series of in vitro and in vivo experiments. Results HPL-exposed CAR T cells exhibited the less differentiated T cell phenotype and gene signature, which displayed inferior short-term killing abilities (compared to their FBS- or ABS-cultured counterparts) but superior proliferative and anti-tumor effects in long-term in vitro coculture experiments. Importantly, in mouse xenograft model, HPL-exposed CAR T cells outperformed their ABS or FBS counterparts against both subcutaneous tumor (P28z T cells against Capan-1PSCA) and systemic tumor (1928z T cells against NALM6). We further observed maintenance of less differentiated T cell phenotype in HPL-exposed 1928z T cells generated from patient’s PBMCs with superior anti-tumor effect in long-term in vitro coculture experiments. Conclusions Our study highlights the importance of serum choice in the generation of CAR T cells for clinical use.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Telecommunications
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

cells, cell, car, pubmed, tumor, article, hpl, google, scholar, cas, fig, fbs, vivo, central, serum, abs, expansion, mice, additional, human, day, phenotype, antitumor, figure, memory, nalm, ccr, tgfβ, file, expanded, expression, antigen, days, cancer, superior, vitro, receptor, study, cultures, multiple, generation, higher, function, journal, clinical, blood, effector, persistence, effects, stem,

Topics {✒️}

cg-prkdcscid il2rgtm1wjl/szj mice gmp-grade xeno-free supplement rat anti-mouse igg1-apc article download pdf tumor-specific t-cells engineered chimeric antigen receptor-modified assess short-term cytotoxicity web-enabled heat mapping anti-epcam-pe antibody enhanced anti-tumor effects maximum anti-tumor response potent anti-tumor response potent anti-tumor activity superior anti-tumor effects vitro anti-tumor effects human platelet lysate vivo anti-tumor effects vivo-cultured anti-tumor chimeric antigen receptor preserve central memory 51cr-release assay representative dot plot crispr-cas9 targeting receptor-engineered adoptive immunotherapy gene-modified cell lines express gfp/fl intravenously tgf-beta signaling retroviral vector encoding superior anti-tumor effect hpl showed slightly cell-mediated rejection human memory stem tailed t-test mesenchymal stem cells privacy choices/manage cookies anti-tumor response anti-tumor effects enhanced long-term mesenchymal stromal cells 51chromium-release assay antigen negative relapse antigen stimulation compared foster ae higher proliferative capacity related subjects long-term assay delaying tumor growth sponsored research agreement living image software cd28 enhances cytotoxicity

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity
         description:Pre-clinical and clinical studies have shown that the infusion of CAR T cells with a naive-like (TN) and central memory (TCM) phenotype is associated with prolonged in vivo T cell persistence and superior anti-tumor effects. To optimize the maintenance of such populations during the in vitro preparation process, we explored the impact of T cell exposure to both traditional [fetal bovine serum (FBS), human AB serum (ABS)] and non-traditional [human platelet lysate (HPL) - a xeno-free protein supplement primarily used for the production of clinical grade mesenchymal stromal / stem cells (MSCs)] serum supplements. Second generation chimeric antigen receptor with CD28 and CD3ζ endodomain targeting prostate stem cell antigen (PSCA) (P28z) or CD19 (1928z) were constructed and used for this study. After retroviral transduction, CAR T cells were divided into 3 conditions containing either FBS, ABS or HPL and expanded for 7 days. To evaluate the effect of different sera on CAR T cell function, we performed a series of in vitro and in vivo experiments. HPL-exposed CAR T cells exhibited the less differentiated T cell phenotype and gene signature, which displayed inferior short-term killing abilities (compared to their FBS- or ABS-cultured counterparts) but superior proliferative and anti-tumor effects in long-term in vitro coculture experiments. Importantly, in mouse xenograft model, HPL-exposed CAR T cells outperformed their ABS or FBS counterparts against both subcutaneous tumor (P28z T cells against Capan-1PSCA) and systemic tumor (1928z T cells against NALM6). We further observed maintenance of less differentiated T cell phenotype in HPL-exposed 1928z T cells generated from patient’s PBMCs with superior anti-tumor effect in long-term in vitro coculture experiments. Our study highlights the importance of serum choice in the generation of CAR T cells for clinical use.
         datePublished:2019-11-28T00:00:00Z
         dateModified:2019-11-28T00:00:00Z
         pageStart:1
         pageEnd:15
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s40425-019-0804-9
         keywords:
            CAR T cells
            Persistence
            Memory phenotype
            Manufacture
            Human platelet lysate
            Oncology
            Immunology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-019-0804-9/MediaObjects/40425_2019_804_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-019-0804-9/MediaObjects/40425_2019_804_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-019-0804-9/MediaObjects/40425_2019_804_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-019-0804-9/MediaObjects/40425_2019_804_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-019-0804-9/MediaObjects/40425_2019_804_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-019-0804-9/MediaObjects/40425_2019_804_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-019-0804-9/MediaObjects/40425_2019_804_Fig7_HTML.png
         isPartOf:
            name:Journal for ImmunoTherapy of Cancer
            issn:
               2051-1426
            volumeNumber:7
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Alejandro Torres Chavez
               affiliation:
                     name:Baylor College of Medicine
                     address:
                        name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mary Kathryn McKenna
               affiliation:
                     name:Baylor College of Medicine
                     address:
                        name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Emanuele Canestrari
               affiliation:
                     name:Cook Regentec
                     address:
                        name:Cook Regentec, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Christina T. Dann
               affiliation:
                     name:Cook Regentec
                     address:
                        name:Cook Regentec, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Carlos A. Ramos
               affiliation:
                     name:Baylor College of Medicine
                     address:
                        name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Premal Lulla
               affiliation:
                     name:Baylor College of Medicine
                     address:
                        name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ann M. Leen
               affiliation:
                     name:Baylor College of Medicine
                     address:
                        name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Juan F. Vera
               affiliation:
                     name:Baylor College of Medicine
                     address:
                        name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Norihiro Watanabe
               url:http://orcid.org/0000-0002-7678-0141
               affiliation:
                     name:Baylor College of Medicine
                     address:
                        name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity
      description:Pre-clinical and clinical studies have shown that the infusion of CAR T cells with a naive-like (TN) and central memory (TCM) phenotype is associated with prolonged in vivo T cell persistence and superior anti-tumor effects. To optimize the maintenance of such populations during the in vitro preparation process, we explored the impact of T cell exposure to both traditional [fetal bovine serum (FBS), human AB serum (ABS)] and non-traditional [human platelet lysate (HPL) - a xeno-free protein supplement primarily used for the production of clinical grade mesenchymal stromal / stem cells (MSCs)] serum supplements. Second generation chimeric antigen receptor with CD28 and CD3ζ endodomain targeting prostate stem cell antigen (PSCA) (P28z) or CD19 (1928z) were constructed and used for this study. After retroviral transduction, CAR T cells were divided into 3 conditions containing either FBS, ABS or HPL and expanded for 7 days. To evaluate the effect of different sera on CAR T cell function, we performed a series of in vitro and in vivo experiments. HPL-exposed CAR T cells exhibited the less differentiated T cell phenotype and gene signature, which displayed inferior short-term killing abilities (compared to their FBS- or ABS-cultured counterparts) but superior proliferative and anti-tumor effects in long-term in vitro coculture experiments. Importantly, in mouse xenograft model, HPL-exposed CAR T cells outperformed their ABS or FBS counterparts against both subcutaneous tumor (P28z T cells against Capan-1PSCA) and systemic tumor (1928z T cells against NALM6). We further observed maintenance of less differentiated T cell phenotype in HPL-exposed 1928z T cells generated from patient’s PBMCs with superior anti-tumor effect in long-term in vitro coculture experiments. Our study highlights the importance of serum choice in the generation of CAR T cells for clinical use.
      datePublished:2019-11-28T00:00:00Z
      dateModified:2019-11-28T00:00:00Z
      pageStart:1
      pageEnd:15
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s40425-019-0804-9
      keywords:
         CAR T cells
         Persistence
         Memory phenotype
         Manufacture
         Human platelet lysate
         Oncology
         Immunology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-019-0804-9/MediaObjects/40425_2019_804_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-019-0804-9/MediaObjects/40425_2019_804_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-019-0804-9/MediaObjects/40425_2019_804_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-019-0804-9/MediaObjects/40425_2019_804_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-019-0804-9/MediaObjects/40425_2019_804_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-019-0804-9/MediaObjects/40425_2019_804_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-019-0804-9/MediaObjects/40425_2019_804_Fig7_HTML.png
      isPartOf:
         name:Journal for ImmunoTherapy of Cancer
         issn:
            2051-1426
         volumeNumber:7
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Alejandro Torres Chavez
            affiliation:
                  name:Baylor College of Medicine
                  address:
                     name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mary Kathryn McKenna
            affiliation:
                  name:Baylor College of Medicine
                  address:
                     name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Emanuele Canestrari
            affiliation:
                  name:Cook Regentec
                  address:
                     name:Cook Regentec, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Christina T. Dann
            affiliation:
                  name:Cook Regentec
                  address:
                     name:Cook Regentec, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Carlos A. Ramos
            affiliation:
                  name:Baylor College of Medicine
                  address:
                     name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Premal Lulla
            affiliation:
                  name:Baylor College of Medicine
                  address:
                     name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ann M. Leen
            affiliation:
                  name:Baylor College of Medicine
                  address:
                     name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Juan F. Vera
            affiliation:
                  name:Baylor College of Medicine
                  address:
                     name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Norihiro Watanabe
            url:http://orcid.org/0000-0002-7678-0141
            affiliation:
                  name:Baylor College of Medicine
                  address:
                     name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal for ImmunoTherapy of Cancer
      issn:
         2051-1426
      volumeNumber:7
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Baylor College of Medicine
      address:
         name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
         type:PostalAddress
      name:Baylor College of Medicine
      address:
         name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
         type:PostalAddress
      name:Cook Regentec
      address:
         name:Cook Regentec, Indianapolis, USA
         type:PostalAddress
      name:Cook Regentec
      address:
         name:Cook Regentec, Indianapolis, USA
         type:PostalAddress
      name:Baylor College of Medicine
      address:
         name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
         type:PostalAddress
      name:Baylor College of Medicine
      address:
         name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
         type:PostalAddress
      name:Baylor College of Medicine
      address:
         name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
         type:PostalAddress
      name:Baylor College of Medicine
      address:
         name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
         type:PostalAddress
      name:Baylor College of Medicine
      address:
         name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Alejandro Torres Chavez
      affiliation:
            name:Baylor College of Medicine
            address:
               name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
               type:PostalAddress
            type:Organization
      name:Mary Kathryn McKenna
      affiliation:
            name:Baylor College of Medicine
            address:
               name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
               type:PostalAddress
            type:Organization
      name:Emanuele Canestrari
      affiliation:
            name:Cook Regentec
            address:
               name:Cook Regentec, Indianapolis, USA
               type:PostalAddress
            type:Organization
      name:Christina T. Dann
      affiliation:
            name:Cook Regentec
            address:
               name:Cook Regentec, Indianapolis, USA
               type:PostalAddress
            type:Organization
      name:Carlos A. Ramos
      affiliation:
            name:Baylor College of Medicine
            address:
               name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
               type:PostalAddress
            type:Organization
      name:Premal Lulla
      affiliation:
            name:Baylor College of Medicine
            address:
               name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
               type:PostalAddress
            type:Organization
      name:Ann M. Leen
      affiliation:
            name:Baylor College of Medicine
            address:
               name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
               type:PostalAddress
            type:Organization
      name:Juan F. Vera
      affiliation:
            name:Baylor College of Medicine
            address:
               name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
               type:PostalAddress
            type:Organization
      name:Norihiro Watanabe
      url:http://orcid.org/0000-0002-7678-0141
      affiliation:
            name:Baylor College of Medicine
            address:
               name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
      name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
      name:Cook Regentec, Indianapolis, USA
      name:Cook Regentec, Indianapolis, USA
      name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
      name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
      name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
      name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
      name:Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA

External Links {🔗}(212)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

6.74s.